NCT03153215View on ClinicalTrials.gov

Sildenafil in Sever Intrauterine Growth Retardation

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 6, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Intra-Uterine Growth Retardation
Interventions
OTHER

treatment

We will offer Sildenafil citrate (20 mg per os three times daily until delivery) as innovative therapy to 23 women with severe IUGR ('Sildenafil-treated') in addition to fish oil and zinc supplementation.

OTHER

Placebo

Placebo tablets similar to Sildenafil will be given to control group in addition to fish oil and zinc supplementation.

Trial Locations (1)

12412

Beni-Suef University, Cairo

All Listed Sponsors
collaborator

Cairo University

OTHER

lead

Beni-Suef University

OTHER

NCT03153215 - Sildenafil in Sever Intrauterine Growth Retardation | Biotech Hunter | Biotech Hunter